1325 AVENUE OF AMERICAS, NEW YORK, NY
Market cap: $6.2M (12/18/2025)
Price: $0.56
Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Brainstorm Cell Therapeutics Enters $182,400 Securities Purchase Agreement
Announces Second Quarter 2025 Financial Results and Provides Corporate Update
Announces Nasdaq Delisting and Transition to OTCQB
News, Material Contracts
Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn®
Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn® for ALS
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
RW
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Prospectus Filed Pursuant to Rule 424(b)(1)